6505--PET Radiopharmaceuticals for Nuclear Medicine Department at the Buffalo VA Medical Center
ID: 36C24225Q0334Type: Combined Synopsis/Solicitation
AwardedApr 14, 2025
$1.9M$1,927,729
AwardeeSOFIE Co. DULLES 20166
Award #:36C24225D0064
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF242-NETWORK CONTRACT OFFICE 02 (36C242)ALBANY, NY, 12208, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/837b0193e23d45c3849ef7a8a74aff94/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of Positron Emission Tomography (PET) Radiopharmaceuticals for the Nuclear Medicine Department at the Buffalo VA Medical Center. This combined synopsis/solicitation aims to acquire various radiopharmaceuticals, including FDG, Cu64, F18-DCFPyl PSMA, Ga-68 DOTATATE, and F18 Florbetaben, under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract structure with a performance period from April 15, 2025, to April 14, 2028. These radiopharmaceuticals are critical for enhancing healthcare services provided to veterans, ensuring they receive reliable access to essential medical supplies. Interested vendors must submit their quotes by March 28, 2025, at 4:00 PM Eastern Time, and can contact Contracting Officer Jonathan Kilgore at jonathan.kilgore@va.gov or 973-676-1000 for further inquiries.

    Point(s) of Contact
    Jonathan KilgoreContracting Officer
    (973) 676-1000
    jonathan.kilgore@va.gov
    Files
    Title
    Posted
    36C24225Q0334_1.docx
    The document outlines a combined synopsis and solicitation notice for PET Radiopharmaceuticals required by the Buffalo VA Medical Center, with the purpose of seeking proposals from suppliers. The document specifies the contracting office, important dates, and details necessary for submission, including the response deadline of March 28, 2025, at 4:00 PM Eastern Time. The solicitation falls under the Product Service Code 6505 and the NAICS Code 325412. The primary contact for inquiries is Contracting Officer Jonathan Kilgore, whose contact information is provided. Interested parties are directed to the agency's website for further details. It emphasizes the need for PET Radiopharmaceuticals, integral to the medical services provided to veterans. All proposals must adhere to the guidelines mentioned in the detailed solicitation document attached to the notice. This solicitation reflects the government's ongoing commitment to procure essential medical supplies to enhance healthcare for veterans.
    S02 - Combined Synopsis Solicitation - PET Radiopharmaceutical.docx
    The Network Contracting Office 02 is issuing a Combined Synopsis/Solicitation for the acquisition of Positron Emission Tomography (PET) Radiopharmaceuticals for the Nuclear Medicine Department at the Buffalo VA Medical Center. The procurement is based on full and open competition under NAICS code 325412, with a small business size standard of 1,300 employees. The contract will be an Indefinite Delivery, Indefinite Quantity (IDIQ) with a performance period from April 15, 2025, to April 14, 2028, including two option years. Vendors are required to quote inclusive prices covering all costs, including shipping and handling. The solicitation outlines specific radiopharmaceuticals needed, their estimated annual usage, and detailed requirements for delivery, including packaging and quality control standards as mandated by regulatory agencies. The awarded contractor must be licensed by the Nuclear Regulatory Commission and provide assurances of compliance with all federal and state regulations. Proposals will be evaluated based on technical capability, past performance, and price, ensuring comprehensive assessment to select the most favorable offer for the government. The deadline for submission of quotes is March 28, 2025.
    S02 - Combined Synopsis Solicitation - PET Radiopharmaceutical.pdf
    The document is a combined synopsis/solicitation for the procurement of commercial radiopharmaceuticals for the Nuclear Medicine Department at the Buffalo VA Medical Center. It outlines the requirements and procedures for interested vendors to submit quotes for various radiopharmaceuticals, including FDG, Cu64, F18-DCFPyl PSMA, Ga-68 DOTATATE, and F18 Florbetaben. The contract is structured as an Indefinite Delivery, Indefinite Quantity (IDIQ) with a three-year term starting April 15, 2025, allowing for full and open competition under NAICS code 325412. Quotes should be all-inclusive, covering shipping and handling, with a guaranteed minimum value of $100,000. Vendors must comply with FDA and NRC regulations and demonstrate their capacity to maintain quality control and safety throughout the contract period. The evaluation criteria for award selection include technical capability, past performance, and price, with an emphasis on compliance with federal standards for handling radioactive materials. The solicitation includes detailed instructions for submission and a deadline for responses. Overall, the document serves as a formal request for proposals aimed at enhancing healthcare services for veterans through reliable access to essential radiopharmaceuticals.
    Similar Opportunities
    Radiopharmaceuticals for Temple Texas VA Medical Center
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide radiopharmaceuticals for the Olin E. Teague VA Medical Center in Temple, Texas, through a short-term contract lasting six months. This procurement is critical for the Nuclear Medicine Department, as the radiopharmaceuticals are essential for medical imaging and therapeutic treatments for various carcinomas, with a total estimated procurement cost of $445,000. The urgency of this requirement is underscored by the short shelf-life of the products, necessitating timely delivery to ensure continuous patient care for veterans. Interested vendors can contact Jeffrey Crysler at jeffrey.crysler@va.gov or by phone at 210-617-5300 for further details.
    6505--Supply, RADIOPHARMACEUTICALS DATSCAN - NBD 1/1 Indianapolis VAMC
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Indianapolis Veterans Affairs Medical Center (VAMC), intends to issue a sole source contract to Medi-Physics, Inc. for the procurement of 20 units of DaTscan Ioflupane, a radiopharmaceutical essential for conducting diagnostic tests. This acquisition is based on the authority of FAR Part 6.302-1, which allows for negotiation with only one responsible source, as Medi-Physics, Inc. is the sole vendor on the Federal Supply Schedule (FSS) contract for this product. The contract is anticipated to be a firm-fixed price agreement with no option years, and responses to this notice must be submitted by 12:00 pm on December 17, 2025, to the primary contact, Rachel MacRae, at rachel.macrae@va.gov or by phone at 734-222-4326.
    Radiology & Imaging FY2025 Solicitation
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is issuing a Request for Proposal (RFP) for the procurement of Radiology Imaging Systems and Accessories, under solicitation number 36H79725R0003. This opportunity encompasses a five-year base period with an option for an additional five years, aiming to establish multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts valued at approximately $6.5 billion over ten years, supporting both the VA and the Department of Defense. The solicitation includes detailed requirements for imaging modalities, compliance with DICOM standards, and contractor responsibilities for training and product support, with proposals due by February 3, 2026. Interested vendors should direct inquiries to LaTonya Whiteside at LaTonya.Whiteside@va.gov by December 18, 2025, to ensure clarity in their submissions.
    6505--Notice of Intent to Award a Sole Source Procurement - Xofigo Radium-223 dichloride
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 17, intends to award a sole source, firm-fixed-price contract to Cardinal Health for the procurement of 660 units of XOFIGO® (Radium-223 dichloride). This procurement is based on a letter from Bayer Healthcare, which designates Cardinal Health as the sole distributor of XOFIGO® in the United States, highlighting the critical nature of this pharmaceutical in treating specific medical conditions. Interested parties may submit capability statements or proposals within seven days of the notice's publication, with the deadline set for December 19, 2025; otherwise, the contract will be awarded to Cardinal Health without further notice. For inquiries, contact Vance Farrell at vance.farrell@va.gov or call 210-694-6379.
    6525--SEP 2025 Consolidation - HTME with Extended Installation Services (Includes Turnkey Services)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of high-tech medical equipment (HTME) with extended installation services, specifically for the September 2025 Consolidation project. This opportunity includes turnkey services for various medical imaging systems, such as Radiographic/Fluoroscopic (R/F), Computed Tomography (CT), and Nuclear Medicine SPECT/CT systems, which are essential for enhancing diagnostic capabilities and patient care within VA facilities. Interested vendors must adhere to strict submission guidelines and deadlines, with proposals due by March 11, 2026, and inquiries directed to the contracting officer, Michael J Kuchyak, at michael.kuchyak@va.gov.
    6525--SEP 2025 Equipment Only Consolidation
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the "SEP 2025 Equipment Only Consolidation" contract, specifically aimed at procuring medical imaging equipment and related services. This procurement encompasses a variety of medical devices, including but not limited to MRI systems, ultrasound units, and radiographic equipment, which are essential for enhancing diagnostic capabilities and improving healthcare delivery to veterans. The contract is unrestricted, with a due date for offers set for January 14, 2026, at 11:59 PM CST, and interested vendors can direct inquiries to Contracting Officer Teresa Rogofsky at teresa.rogofsky@va.gov. The solicitation includes detailed specifications and requirements, emphasizing compliance with security standards and the need for comprehensive training and support services.
    65--65VA RFP-797-655A-30-0001-R6 Solicitation Refresh
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is issuing a solicitation for the procurement of X-Ray Equipment and Supplies under the Federal Supply Schedule FSC Group 6525. This opportunity involves multiple award, fixed-price, indefinite delivery-indefinite quantity (IDIQ) contracts with Economic Price Adjustment (EPA) provisions, aimed at ensuring a continuous supply of essential imaging equipment and supplies for medical, dental, and veterinary use. The solicitation, designated as RFP-797-655A-30-0001-R6, is a refresh of a previous solicitation and remains open for new offers without a specified closing date, with contract performance expected to commence upon award and last for five years. Interested vendors can reach out to the FSS Help Desk at 708-786-7737 or via email at Fss.Help@va.gov for further inquiries.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    Q522--VHSO Teleradiology Services- Fayetteville (564) SDVOSB competitive
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for Teleradiology Services for the Veterans Healthcare System of the Ozarks (VHSO) in Fayetteville, Arkansas. This procurement involves providing off-site interpretation of various imaging studies, including X-Ray, Ultrasound, CT, and MRI, under a fixed-price indefinite-delivery, indefinite-quantity (IDIQ) contract valued at up to $3,100,000, with a guaranteed minimum of $1,000. The services are critical for ensuring timely and accurate medical diagnoses, adhering to stringent standards set by the VA and other regulatory bodies. Interested Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) must submit their proposals by January 6, 2026, at 2:00 PM CST, and can contact Contract Specialist Karen Battie at Karen.Battie@va.gov for further information.